Drug Type Small molecule drug |
Synonyms A-270 |
Target |
Mechanism SLC26A3 inhibitors(Chloride anion exchanger inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hyperoxaluria | Preclinical | US | - | |
Urolithiasis | Preclinical | US | - |